S&P Equity Research downgrades Cardinal Health (NYSE: CAH) from Buy to Hold. Price target lowered from $78 to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE